Chronic Obstructive Pulmonary Disease
Showing NaN - NaN of 77
COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
- +2 more
-
Torrance, California
- +25 more
Sep 28, 2023
A Pragmatic Real-world Multicentre Observational Research Study
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- myCOPD
-
London, United Kingdommy mhealth Limited
Apr 18, 2023
COPD Trial in Canada, United Kingdom, United States (Azithromycin, HP xenon (¹²?XE))
Recruiting
- Chronic Obstructive Pulmonary Disease
- Azithromycin
- HP xenon (¹²⁹XE)
-
Kansas City, Kansas
- +5 more
Feb 2, 2023
COPD Trial in London (Exposure to London Underground ambient particulate matter, Exposure to London air ambient particulate
Recruiting
- Chronic Obstructive Pulmonary Disease
- Exposure to London Underground ambient particulate matter
- Exposure to London air ambient particulate matter
-
London, United KingdomImperial Clinical Research Facility
Jan 19, 2023
COPD Trial in Worldwide (Itepekimab SAR440340)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Itepekimab SAR440340
-
Oklahoma City, Oklahoma
- +11 more
Jan 17, 2023
Quality of Life in Patients With Chronic Respiratory Failure
Recruiting
- Chronic Obstructive Pulmonary Disease
- +3 more
- Questionnaire
-
London, United KingdomGuy's and St. Thomas NHS Foundation Trust
Dec 29, 2022
COPD Trial in Worldwide (Ensifentrine, Placebo)
Active, not recruiting
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Peoria, Arizona
- +133 more
Dec 5, 2022
Lung Disease and Impact on Physical and Mental Health
Active, not recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
London, United Kingdom
- +1 more
Nov 18, 2022
Observational Study of Obstructive Lung Disease (NOVELTY)
Active, not recruiting
- Asthma
- +2 more
- Blood draw
- +3 more
-
Loma Linda, California
- +302 more
Nov 22, 2022
COPD Trial (Metformin, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Metformin
- Placebo
-
London, Greater London, United KingdomImperial College Respiratory Research Unit, St Mary's Hospital
Aug 24, 2022
COPD Trial in Worldwide (Astegolimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Astegolimab
- Placebo
-
Andalusia, Alabama
- +170 more
Aug 4, 2022
COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Dupilumab SAR231893
- +4 more
-
Cullman, Alabama
- +334 more
Jun 14, 2022
Asthma, COPD Trial in London, Manchester (SelK2 (Part 1), Placebo (Part 1), SelK2 (Part 2))
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- SelK2 (Part 1)
- +3 more
-
London, United Kingdom
- +1 more
Feb 1, 2022
COPD Trial in Worldwide (CHF 5259, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- CHF 5259
- Placebo
-
Sevlievo, Bulgaria
- +28 more
Oct 28, 2021
Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- Therapeutic Dose 1
- +3 more
-
London, Tooting, United KingdomRichmond Pharmacology Ltd
Oct 15, 2021
COPD, Chronic Respiratory Hypercapnic Failure, Neuromuscular Disease Trial in London (non-invasive ventilation heated
Completed
- Chronic Obstructive Pulmonary Disease
- +3 more
- non-invasive ventilation heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)
-
London, United KingdomSt Thomas' Hospital
Sep 30, 2021
Airway Microenvironment in Patients Undergoing Surgical and
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
London, Chelsea, United Kingdom
- +1 more
Sep 14, 2021
The BLF Early COPD Development Partnership Grant
Active, not recruiting
- Chronic Obstructive Pulmonary Disease
-
London, United KingdomRoyal Brompton and Harefield NHS Foundation Trust
Aug 25, 2021
COPD Trial in London (NIV, ECCO2R)
Completed
- Chronic Obstructive Pulmonary Disease
- NIV
- ECCO2R
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Aug 4, 2021
Chronic Bronchitis, COPD Trial in Worldwide (ION-827359, Placebo)
Terminated
- Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease
- ION-827359
- Placebo
-
Jindrichuv Hradec, Czechia
- +14 more
May 11, 2021
COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,
Terminated
- Chronic Obstructive Pulmonary Disease
- Alpha1-antitrypsin Deficiency
- ARALAST NP 60 mg/kg
- +4 more
-
Peoria, Arizona
- +16 more
Apr 17, 2021
Respiratory Failure, Neuromuscular Disease, Chest Wall Disorder Trial in London (AutoVPAP™, VPAPIIIST-A™)
Withdrawn
- Respiratory Failure
- +4 more
- AutoVPAP™
- VPAPIIIST-A™
-
London, United KingdomRoyal Brompton Hospital
Apr 14, 2021
COPD Trial in London (Humidified nasal high-flow device)
Completed
- Chronic Obstructive Pulmonary Disease
- Humidified nasal high-flow device
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Apr 9, 2021
COPD Trial in Germany, United Kingdom (AZD8871, Anoro® Ellipta®)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD8871
- Anoro® Ellipta®
-
Berlin, Germany
- +4 more
Nov 24, 2020
COPD Trial in London (Flutter valve exercises, Flutter Sham exercises, Flutter and bronchodilator exercises)
Completed
- Chronic Obstructive Pulmonary Disease
- Flutter valve exercises
- +2 more
-
London, United KingdomAsthma Lab, Royal Brompton Hospital, National Heart and Lung Ins
Feb 13, 2020